Clinical Trials on Sporadic ALS (SALS) in Poland

Total 22798 results

Collegium Medicum w Bydgoszczy

Recruiting

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study in Patients After Organ Transplantation (DANTE-SIRIO 8)

SARS-CoV2 Infection | SARS-CoV2 Antibodies

Poland
Biogen
Ionis Pharmaceuticals, Inc.

Active, not recruiting

Long-Term Evaluation of BIIB067 (Tofersen)

ALS Caused by Superoxide Dismutase 1 (SOD1) Mutation

United States, Canada, Italy, Belgium, New Zealand, Japan, France, Germany, United Kingdom
University of California, Irvine
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Active, not recruiting

Sporadic Inclusion Body Myositis Natural History Study (INSPIRE-IBM)

Inclusion Body Myositis | Sporadic Inclusion Body Myositis

United States
Collegium Medicum w Bydgoszczy

Active, not recruiting

Determinants of the Level of Anti-SARS-CoV-2 IgG ANTibodiEs After Vaccination Study (DANTE-SIRIO 7)

SARS-CoV2 Infection | SARS-CoV2 Antibodies

Poland
Polish Society of Disaster Medicine

Active, not recruiting

COVID-19 Antigen Rapid Test Kit (SETCOV)

SARS-CoV2 Infection

Poland
Collegium Medicum w Bydgoszczy

Completed

Impact of PCSK9 Inhibition on Clinical Outcome in Patients During the Inflammatory Stage of the COVID-19 (IMPACT-SIRIO 5)

Sars-CoV-2 Infection

Poland
Barrow Neurological Institute
ALS Association

Completed

Deep Phenotyping in Patients With ALS

Motor Neuron Disease | ALS

United States
Novartis Pharmaceuticals

Completed

Efficacy and Safety of Bimagrumab/BYM338 at 52 Weeks on Physical Function, Muscle Strength, Mobility in sIBM Patients (RESILIENT)

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
US Department of Veterans Affairs
New York State Department of Health

Completed

A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients (ALS)

ALS (Amyotrophic Lateral Sclerosis)

United States
Novartis Pharmaceuticals

Completed

An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203

Sporadic Inclusion Body Myositis

United States, Belgium, Italy, Australia, Netherlands, Switzerland, France, United Kingdom, Denmark, Japan
The Avicena Group

Unknown

Study of Creatine Monohydrate in Patients With Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

United States
Center for Neurologic Study, La Jolla, California,
State University of New York - Upstate Medical University; ALS Association

Completed

Clinical Trial Nuedexta in Subjects With ALS

Amyotrophic Lateral Sclerosis (ALS)

United States
Columbia University
Biogen; ALS Association

Completed

Genomic Translation for Amyotrophic Lateral Sclerosis Care (GTAC)

ALS

United States, United Kingdom
Celltrion

Completed

To Evaluate the Safety, Tolerability and Pharmacokinetics of CT-P63 in Healthy Subjects

SARS-CoV-2 Infection

Poland
Richard Barohn, MD

Completed

Rasagiline in Subjects With Amyotrophic Lateral Sclerosis (ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
Medical University of Bialystok

Completed

Assessment of the Impact of COVID-19 Pandemic on Residents Training and Mental Health in Poland

SARS-CoV-2

Poland
Providence Health & Services
OncoSec Medical Incorporated

Completed

CORVax12: SARS-CoV-2 Spike (S) Protein Plasmid DNA Vaccine Trial for COVID-19 (SARS-CoV-2) (CORVax12)

SARS-CoV-2

United States
Lucyna Mastalerz

Recruiting

Long-term Aspirin Therapy as a Predictor of Decreased Susceptibility to SARS-CoV-2 Infection in Aspirin-Exacerbated Respiratory Disease (AERD-CoV19)

AERD - Aspirin Exacerbated Respiratory Disease

Poland
Silesian Centre for Heart Diseases
Medical University of Silesia; Medical Research Agency, Poland

Unknown

The Assessment of the Prevalence, Clinical Course and Treatment of COVID-19 Complications

COVID-19 | Coronavirus Infection | Complications | Sars-CoV2

Poland
Synapse Biomedical

Completed

Humanitarian Device Exemption Post-Approval Study of NeuRx Diaphragm Pacing System for Amyotrophic Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS)

United States
Barrow Neurological Institute
ALS Association; Muscular Dystrophy Association; Synapse Biomedical

Completed

Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS) (DPS in ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States
National Institute for Tuberculosis and Lung Diseases...
Medical University of Warsaw

Active, not recruiting

Impact of Severe Acute Respiratory Syndrome (SARS-CoV-2/COVID-19) Related Pneumonia on Lung Function and Structure.

Pneumonia, Viral | Covid19 | SARS-CoV Infection | Pulmonary Function

Poland
Massachusetts General Hospital
National Institute of Neurological Disorders and Stroke (NINDS)

Completed

Clinical Trial Ceftriaxone in Subjects With ALS

Amyotrophic Lateral Sclerosis | ALS

United States, Canada
Alexion Pharmaceuticals

Terminated

An Efficacy and Safety Study of Ravulizumab in ALS Participants

Amyotrophic Lateral Sclerosis | ALS

United States, Spain, Italy, Belgium, Canada, Switzerland, Australia, Germany, Denmark, Israel, Sweden, France, Ireland, United Kingdom, Japan, Netherlands, Poland
Independent Public Clinical Hospital No. 4 in Lublin

Recruiting

The Use of Amantadine in the Prevention of Progression and Treatment of COVID-19 Symptoms (COV-PREVENT)

COVID-19 | SARS-CoV-2

Poland
Cytokinetics

Completed

A Study for Patients Who Completed VITALITY-ALS (CY 4031) (VIGOR-ALS)

Amyotrophic Lateral Sclerosis (ALS)

United States, Netherlands, Canada, Belgium, United Kingdom, France, Germany, Ireland, Italy, Portugal, Spain
Hanna Czajka
Medical Research Agency, Poland

Unknown

Clinical Trial Evaluating the Effect of BCG Vaccination on the Incidence and Severity of SARS-CoV-2 Infections Among Healthcare Professionals During the COVID-19 Pandemic in Poland

Covid19 | SARS-CoV Infection | BCG Vaccination Reaction

Poland
GlaxoSmithKline
CureVac

Completed

Safety, Reactogenicity, and Immunogenicity Trial of CV2CoV mRNA Vaccine Against SARS-CoV-2 in Seropositive Adult Participants

SARS-CoV-2

United States
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Immunogenicity of mRNA-1273 Vaccine to Prevent COVID-19 in Adult Organ Transplant Recipients and in Healthy Adult Participants

SARS-CoV-2

United States
Wroclaw Medical University

Completed

COVID-19 in Polish Ice Swimmers. (ICE)

Covid19 | Hypothermia | SARS-CoV Infection | Hypothermia Due to Cold Environment | Resistance, Disease

Poland
Oregon Health and Science University
OHSU Knight Cancer Institute

Withdrawn

Assessing Hydroxychloroquine in Patients With SARS-CoV-2 (COVID-19)

COVID-19 | SARS-CoV-2

United States
Novartis Pharmaceuticals

Completed

Study of the Efficacy and Safety of Secukinumab in Participants With Active Psoriatic Arthritis With Axial Skeleton Involvement (MAXIMISE)

Axial Psoratic Arthritis

Belgium, Israel, Spain, Switzerland, Greece, Italy, Bulgaria, Germany, Hungary, Estonia, United Kingdom, Poland, France, Czechia, Russian Federation, Romania, Ireland, Finland
AstraZeneca

Completed

AZD7442 Pharmacokinetics, Pharmacodynamics, and Safety Evaluation in Pediatrics (TRUST)

SARS-CoV-2

United States, Belgium, United Kingdom, Brazil, Germany
ModernaTX, Inc.

Completed

A Study to Evaluate the Immunogenicity and Safety of mRNA Vaccine Boosters for SARS-CoV-2 (COVID-19) Variants

SARS-CoV-2

United States
VA Office of Research and Development
Food and Drug Administration (FDA); Biomedical Advanced Research and Development...

Recruiting

COVID-19 Pharmacotherapy Effectiveness in the VA Healthcare System (COPE-VA)

Influenza | RSV | COVID-19, SARS-CoV-2 Infection

United States
Massachusetts General Hospital
Northwestern University; University of Florida; University of Minnesota; Henry... and other collaborators

Recruiting

ALS/MND Natural History Study Data Repository

ALS | Kennedy Disease | MND (Motor Neurone DIsease) | PLS | PMA - Progressive Muscular Atrophy | PBP - Progressive Bulbar Palsy

United States, Italy
Johns Hopkins University
National Institute of Allergy and Infectious Diseases (NIAID); United States... and other collaborators

Completed

Convalescent Plasma to Limit SARS-CoV-2 Associated Complications (CSSC-004)

SARS-CoV 2

United States
The Miriam Hospital

Completed

Short Term Corticosteroids in SARS-CoV2 Patients

SARS-CoV 2 | Covid19 | Dexamethasone | Steroids | Corticosteroids

United States
Novavax

Completed

Study to Compare the Immunogenicity and Safety of 3 Lots of NVX-CoV2373 in Adults

COVID-19 | SARS-CoV-2 Infection

United States
Providence Health & Services
Providence Cancer Center, Earle A. Chiles Research Institute; Center for Outcomes...

Suspended

Hydroxychloroquine in Patients With Newly Diagnosed COVID-19 Compared to Standard of Care

COVID-19 | Corona Virus Infection | SARS-CoV-2 | 2019-nCoV | 2019 Novel Coronavirus

United States
ModernaTX, Inc.
National Institute of Allergy and Infectious Diseases (NIAID); Biomedical Advanced...

Completed

A Study to Evaluate Efficacy, Safety, and Immunogenicity of mRNA-1273 Vaccine in Adults Aged 18 Years and Older to Prevent COVID-19

SARS-CoV-2

United States
University Medical Center Groningen
Radboud University Medical Center; Erasmus Medical Center; Academisch Medisch... and other collaborators

Completed

RECOVAC Repeated Vaccination Study

Kidney Diseases | Covid19 | SARS-CoV2 Infection | Vaccine Response Impaired

Netherlands
ModernaTX, Inc.

Completed

A Study to Evaluate Safety and Effectiveness of mRNA-1273 COVID-19 Vaccine in Healthy Children Between 6 Months of Age and Less Than 12 Years of Age

SARS-CoV-2

United States, Canada
University of Miami
National Institute of Neurological Disorders and Stroke (NINDS); National Institutes... and other collaborators

Recruiting

Clinical Procedures to Support Research in ALS (CAPTURE-ALS)

Amyotrophic Lateral Sclerosis | Primary Lateral Sclerosis | Progressive Muscular Atrophy | ALS-Frontotemporal Dementia

United States
MP Biomedicals, LLC
EDP Biotech

Completed

COVID-19 MP Biomedicals SARS-CoV-2 Ag OTC: Clinical Evaluation

COVID-19 | SARS-CoV2 Infection

United States
ModernaTX, Inc.
Biomedical Advanced Research and Development Authority

Active, not recruiting

A Study to Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19 (TeenCove)

SARS-CoV-2

United States, Dominican Republic
ModernaTX, Inc.

Recruiting

A Study to Evaluate the Safety and Immunogenicity of the mRNA COVID-19 Vaccines in Healthy Children Between 6 Months to Less Than 6 Years of Age

SARS-CoV-2

United States, Puerto Rico
Karol Wierzbicki
Medtronic Poland Spółka z ograniczoną odpowiedzialnością; Cor Aegrum Foundation... and other collaborators

Completed

Exercise Tolerance in Patients With Implanted Left Ventricular Assist Device

Left Ventricular Assist Device

Poland
Jagiellonian University
University Hospital in Krakow

Not yet recruiting

Beta-blockade in Unruptured Intracranial Aneurysm (BBLURAN)

Intracranial Aneurysm

Poland
The Greater Poland Cancer Centre

Recruiting

Focal Salvage Brachytherapy Study (FocaSaBra) (FocaSaBra)

Prostate Cancer

Poland

Clinical Trials on Sporadic ALS (SALS) in Poland

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Algeria

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations